Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Foster Wheeler Acquires Pharma and Biotech Construction Management Company

By Pharmaceutical Processing | January 9, 2013

Foster Wheeler AG announced today that it has acquired Yonkers Industries, Inc., a 30-year-old US-based firm that specializes in the management of construction and commissioning of pharmaceutical and biotech facilities, with capabilities to also manage the full EPCm (Engineering, Procurement and Construction Management) of such facilities.

With offices in California, North Carolina and Puerto Rico, Yonkers Industries has approximately 200 professionals. Through its participation in a project-services partnership called Modular Partners, Yonkers also has the ability to provide modular project delivery services on a worldwide basis.

“The acquisition of Yonkers Industries gives our pharmaceutical business a construction management capability in North America,” said Kent Masters, Chief Executive Officer of Foster Wheeler AG. “Yonkers has a global reputation for excellence in contract execution, and the addition of this construction management capability immediately strengthens our value proposition to pharmaceutical and biotech clients.”

Masters added, “Foster Wheeler Biokinetics, our US-based pharmaceutical unit, will experience the most immediate benefit from this acquisition – as the client portfolios and geographic coverage of the two companies fit together quite effectively. We believe that the project and construction management skills of Yonkers are a perfect complement to the biotech engineering expertise of Biokinetics.”

 

 

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards